It was sometime during the COVID-19 pandemic when Wegovy and Ozempic hit mainstream awareness. Since then, they have taken the weight loss industry by storm. It’s worth noting from the start that ...

Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is sold under the brand names Victoza and Saxenda. The class of drugs ...

At the hearing, Novo CEO Lars Fruergaard Jørgensen said the company would consider new talks with insurers about the list prices of Wegovy and Ozempic if they follow through on a pledge to keep the ...

The obesity-drug hype that fueled huge gains in Novo Nordisk A/S looks to be running out of steam. Novo shares fell as much as 4.6% to a seven-month low on Friday after a JPMorgan Chase & Co ...

Novo shares fell as much as 4.6% to a seven-month low on Friday after a JPMorgan Chase & Co. analyst said the Danish firm’s third-quarter results may show slower-than-expected sales of its blockbuster ...

Steady newsflow concerning potential rivals to Novo Nordisk’s weight-loss and diabetes drugs Ozempic and Wegovy has dented the investment case, said Soren Lontoft Hansen, senior analyst at ...

GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Obesity medicine professionals identified six common mistakes people make on weight ...

What to Eat on Wegovy Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and over. But it’s not a miracle drug, so knowing ...

Ozempic and Wegovy. Now the question is whether those prices will change. Vermont Senator Bernie Sanders, chair of the Senate health committee, focused his sights not only on Novo Nordisk ...

Martin Whyte has received research funding from AstraZeneca. The arrival of GLP-1 analogue drugs (such as Wegovy) marked a huge shift in the weight loss drug market. These drugs have been shown to ...

But the explosion of interest in GLP-1s such as Novo Nordisk's Wegovy and Saxenda, their exorbitant costs, and the number of people who meet FDA guidelines to take them is unmatched, said Paul ...